Actelion's CEO Said to Reject Full Takeover by Johnson & Johnson (JNJ), May Sell Unit - Source

November 30, 2016 11:14 AM EST Send to a Friend
Despite an offer from Johnson & Johnson (NYSE: JNJ), Actelion's (OTC: ALIOY) CEO Jean-Paul Clozel has decided that the company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login